Story

Fevertree Shares Fall as U.S. Margin Concerns Overshadow Earnings Beat

ENTHMSVIIDZHZH-TWJAKOHI
Sep 10, 20261 min read
Fevertree Shares Fall as U.S. Margin Concerns Overshadow Earnings Beat
Text size
Background

Shares in Fevertree Drinks (LSE:FEVR) fell sharply on Tuesday after the premium beverage maker's interim results failed to allay investor concerns over profitability in the United States, its most important growth market. The stock was down 6.4% to trade at 765.5 pence, moving closer to its 52-week low.

Results Top Estimates

For the six months ended June 30, 2026, Fevertree reported financial results that surpassed analyst expectations. The company's performance highlights include:

  • Adjusted Revenue: £184.2 million, slightly ahead of the £182.2 million forecast by analysts at Jefferies.
  • Adjusted EBITDA: £20.1 million, beating the Jefferies estimate of £19.5 million.
  • Interim Dividend: Increased by 2% to 6.09 pence per share.

Despite the headline beat, the market reaction was negative, suggesting investors were looking for a more substantial outperformance to justify a re-rating of the stock.

U.S. Profitability in Focus

Sample IUX Markets – In-articleAd

The primary driver of the stock's decline was persistent concern over the company's U.S. margins. While Fevertree is investing heavily in marketing to capture market share in North America, this expenditure is compressing profitability.

The solid performance in other regions was overshadowed by the U.S. headwinds. Revenue in the UK returned to growth with a 3% increase to £49.5 million, while Europe delivered a strong 10% gain on a constant-currency basis to £49.6 million.

Market Outlook

Following the results, analysts at Jefferies maintained their full-year 2026 forecasts for revenue at £400.7 million and EBITDA at £50.1 million. The lack of an upward revision signaled to the market that a significant earnings upgrade cycle is not imminent, disappointing bullish investors.

The session reflects a classic "sell the news" scenario, where a company meets but does not meaningfully exceed high expectations. The market's focus remains squarely on whether Fevertree's significant investment in the U.S. can translate into sustainable and profitable growth.

Read next

More on Stocks
Back to latest news

LATEST